HOYA (7741) FY2027 Q1 Earnings Report

Quick View

Executive Summary

In addition to revenue growth in both the Information & Communications and Life Care segments, margin improvement progressed, resulting in higher revenue and profit, with operating income growth outpacing revenue growth. Revenue was ¥2557.4B (+16.0% YoY), operating income was ¥826.3B (+30.0%), profit before tax, corresponding approximately to ordinary income, was ¥859.9B (+27.7%), and net income attributable to owners of the parent was ¥657.9B (+26.9%). The primary drivers of profit growth were the expanded mix of high-value-added products in the Information & Communications Business and cost rationalization in Life Care. The absence of the ¥19.1B impairment loss recorded in the year-ago period also provided an earnings boost.

Factors Affecting Earnings

【Revenue】Revenue was ¥2557.4B, up +16.0% YoY. The Information & Communications Business (+22.7%) led growth due to expanding demand for semiconductor mask blanks and HDD substrates, while the Life Care Business (+12.8%) also contributed through growth in eyeglass lenses, intraocular lenses, and artificial bone.

【Profitability】Operating income was ¥826.3B, up +30.0% YoY, representing a growth rate 14.0pt above the revenue growth rate. The operating margin improved to 32.3% from 28.8% in the year-ago period, an improvement of 3.5pt. The ¥19.1B impairment loss recorded in the year-ago period did not recur in the current period, creating a comparative uplift. Meanwhile, the current period included ¥8.7B in other non-recurring gains and losses in the Information & Communications Business, partially offset by ¥5.4B in foreign exchange losses within operating classifications. The difference between profit before tax and net income was generally within the scope of the tax burden, with an effective tax rate of 23.4%, and no significant one-time factors were identified. In conclusion, the company achieved higher revenue and profit.

Segment Analysis

The Information & Communications Business is the core business, accounting for 39.5% of revenue and generating 65.0% of operating income (profit from ordinary operating activities). Revenue in this business increased to ¥1009.5B (+22.7%), while profit rose to ¥556.1B (+27.8%); the margin remained high and expanded to 55.1% from 52.9% in the prior-year period, an improvement of +2.2pt. The Life Care Business generated revenue of ¥1547.9B (+12.8%) and profit of ¥299.8B (+23.6%), with the margin improving to 19.4% from 17.7% in the prior-year period, an improvement of +1.7pt. Both segments achieved profit growth exceeding their respective revenue growth rates, with overall earnings growth led by improved profitability in Information & Communications.

Key Financial Indicators

Profitability: ROE 25.6% (annualized), operating margin 32.3% (28.8% in the prior-year period)
Cash flow quality: Operating CF / Net Income 1.06x (healthy at 1.0x or above), FCF ¥628.9B
Investment efficiency: Capital Expenditures / Depreciation and Amortization 0.71x (below 1.0x indicates an investment restraint phase)
Financial soundness: Equity Ratio 78.0%, current ratio approximately 491%

Cash Flow Analysis

Operating CF was ¥700.0B, up +22.3% YoY, and cash conversion of earnings was sound at 1.06x net income. Investing CF was △¥71.1B, primarily due to capital expenditures of ¥113.1B. Financing CF was △¥882.4B, mainly reflecting dividend payments of ¥569.1B and share repurchases of ¥280.5B. FCF was calculated at ¥628.9B, based on investing CF of △¥71.1B rather than operating CF of ¥700.0B less capital expenditures of ¥113.1B. Cash generation was moderately strong relative to standard levels; however, total dividends and share repurchases of ¥849.6B exceeded FCF, resulting in a decline in cash balances during the quarter.

Earnings Quality

The difference between profit before tax of ¥859.9B and net income of ¥657.9B was ¥201.6B in income taxes and other taxes. The effective tax rate of 23.4% was within a normal range, and no significant one-time factors were identified. Non-operating income, including interest income of ¥27.6B and equity-method income of ¥2.4B, was relatively small at approximately 1.2% of revenue. Operating CF exceeded net income at 1.06x, indicating low accruals and good earnings quality. The absence of the ¥19.1B impairment loss recorded in the year-ago period should be noted as a temporary factor that boosted the operating income growth rate.

Earnings Forecast and Guidance

Q1 progress against the full-year forecast—revenue of ¥5210.0B, operating income of ¥1650.0B, and net income of ¥1310.0B—was 49.1% for revenue, 50.1% for operating income, and 50.2% for net income, substantially exceeding the standard progress rate of 25% assuming an even quarterly distribution. An earnings forecast revision was disclosed during the quarter, and the high progress rate appears to have been supported by expanding demand in the Information & Communications Business. Going forward, foreign exchange trends in the second half and the sustainability of semiconductor-related demand will be the key focus areas.

Shareholder Returns

Q1 dividend payments were ¥569.1B (¥170.00 per share), resulting in a Payout Ratio of 86.5% relative to net income attributable to owners of the parent of ¥657.9B. Including share repurchases of ¥280.5B, the Total Return Ratio based on total shareholder returns of ¥849.6B was 129.1%. A new resolution was approved for share repurchases totaling ¥2000B, with a ceiling of 1000万 shares, from August 2026 through March 2027. This is positioned as a capital policy intended to optimize the company’s net cash position. The dividend forecast will be determined on an individual basis after taking future funding needs and other factors into account, and remains undecided at present.

Catalysts

【Short Term】The earnings briefing scheduled for July 31, 2026, and progress on the share repurchase program beginning in August (¥2000B, with a ceiling of 1000万 shares).

【Long Term】Progress in considering the transfer of the endoscope business to a third party and other strategic options, as well as development trends for next-generation semiconductor blanks such as High NA for EUV.

Industry Benchmarks (Reference; Compiled by the Company)

Profitability and Returns

Profitability is substantially above the industry median, representing an exceptionally high margin level even within the manufacturing sector.

Growth and Capital Efficiency

The revenue growth rate also ranks in the upper tier of the industry, demonstrating the ability to achieve both profitability and growth.

※Source: Compiled by the Company

Risk Factors

1. Core Segment Concentration Risk: The Information & Communications Business accounts for 65.0% of operating income, making company-wide performance highly sensitive to the maintenance of the segment’s 55.1% profit margin. Fluctuations in semiconductor-related demand could have a significant impact on earnings.

2. Continued Revenue Decline in the Chinese Market: Revenue declines and customer inventory adjustments continue in the China businesses for endoscopes, intraocular lenses, and chromatography media, exerting downward pressure on part of the Life Care Business.

3. Balance Between Shareholder Returns and Cash Generation: Q1 dividends and share repurchases totaled ¥849.6B, exceeding FCF of ¥628.9B, while cash balances declined by ¥253.5B during the quarter. There is scope to monitor the balance with cash generation capacity on a full-year basis.

Key Earnings Highlights

1. The profit margin of the Information & Communications Business improved by +2.2pt YoY to 55.1%. The expansion of the high-value-added product mix is notable as a structural driver of improved company-wide profitability.

2. Q1 revenue and profit progress was approximately 50% against the full-year forecast, substantially exceeding the standard quarterly progress rate of 25%. The temporary factor of the reversal of the prior-year impairment loss also contributed in part, making the reproducibility of this performance in subsequent quarters a key point to monitor.

3. The resolution for share repurchases on the scale of ¥2000B is intended to optimize net cash and can be viewed as a turning point in capital policy against the backdrop of strong financial soundness, reflected in an Equity Ratio of 78.0%.

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,432–¥3,638 at ±1% for the cost of equity, and ¥3,520–¥3,552 at ±0.1 for ω.

Notes:

• Since net income progress against the full-year forecast (50%) exceeds the standard level (25%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of schedule tend to exceed their forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated through AI-integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional advisor as necessary.

---End of Report---